✦ LIBER ✦

Clinical and genetic description of a family with Charcot–Marie–Tooth disease type 1B from a transmembrane MPZ mutation

✍ Scribed by Scott D. Z. Eggers; Sanjay C. Keswani; Giorgia Melli; David R. Cornblath

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 70 KB
Volume: 29
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.20034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel mutation of the myelin Po gene in

Novel mutation of the myelin Po gene in a pedigree with Charcot-Marie-Tooth disease type 1b

✍ Ikegami, Tohru; Ikeda, Hiroyuki; Mitsui, Tetsuo; Hayasaka, Kiyoshi; Ishii, Shoug 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 15 KB 👁 2 views

Clinical and pathological phenotype of t

Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: A 20-year study

✍ Dr. Thomas D. Bird; George H. Kraft; Hillary P. Lipe; Kimbra L. Kenney; S. Mark 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

Charcot-Marie-Tooth type 1B is an uncommon form of hereditary motor and sensory neuropathy caused by mutations in the Po myelin protein gene on chromosome 1. We report here a 20-year observation of 13 members of the first family with Charcot-Marie-Tooth disease to demonstrate linkage to chromosome 1

Late-onset Charcot-Marie-Tooth type 2 di

Late-onset Charcot-Marie-Tooth type 2 disease with hearing impairment associated with a novel Pro105Thr mutation in the MPZ gene

✍ Dagmara Kabzińska; Teresa Korwin-Piotrowska; Hanna Drechsler; Hanna Drac; Irena 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

A Recurrent loss-of-function alanyl-tRNA

A Recurrent loss-of-function alanyl-tRNA synthetase (AARS ) mutation in patients with charcot-marie-tooth disease type 2N (CMT2N)

✍ Heather M. McLaughlin; Reiko Sakaguchi; William Giblin; NIH Intramural Sequencin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

Charcot-Marie-Tooth (CMT) disease comprises a heterogeneous group of peripheral neuropathies characterized by muscle weakness and wasting, and impaired sensation in the extremities. Four genes encoding an aminoacyl-tRNA synthetase (ARS) have been implicated in CMT disease. ARSs are ubiquitously expr